Johnson & Johnson (NYSE:JNJ) is included among the 12 Best Dow Jones Dividend Stocks to Buy According to Hedge Funds. Scotiabank Raises Johnson & Johnson (JNJ) Target on Strong Quarterly Results On January 22, Scotiabank lifted its price target on Johnson & Johnson (NYSE:JNJ) to $265 from$230. The firm reiterated an Outperform rating after the company’s Q4 results. The bigger takeaway was how well J&J seems to be managing its patent pressures. Stelara is already dealing with biosimilar competition, and ...